Logo image of OMI

OWENS & MINOR INC (OMI) Stock Fundamental Analysis

USA - NYSE:OMI - US6907321029 - Common Stock

2.95 USD
-0.23 (-7.23%)
Last: 11/10/2025, 8:19:58 PM
2.9507 USD
+0 (+0.02%)
After Hours: 11/10/2025, 8:19:58 PM
Fundamental Rating

3

Overall OMI gets a fundamental rating of 3 out of 10. We evaluated OMI against 100 industry peers in the Health Care Providers & Services industry. OMI has a medium profitability rating, but doesn't score so well on its financial health evaluation. OMI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

OMI had positive earnings in the past year.
In the past year OMI had a positive cash flow from operations.
In multiple years OMI reported negative net income over the last 5 years.
Each year in the past 5 years OMI had a positive operating cash flow.
OMI Yearly Net Income VS EBIT VS OCF VS FCFOMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

With a Return On Assets value of -28.95%, OMI is not doing good in the industry: 84.00% of the companies in the same industry are doing better.
With an excellent Return On Invested Capital value of 13.26%, OMI belongs to the best of the industry, outperforming 91.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for OMI is below the industry average of 9.45%.
The 3 year average ROIC (6.37%) for OMI is below the current ROIC(13.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -28.95%
ROE N/A
ROIC 13.26%
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
OMI Yearly ROA, ROE, ROICOMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

The Operating Margin of OMI (2.85%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of OMI has grown nicely.
OMI has a Gross Margin (22.79%) which is in line with its industry peers.
OMI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.85%
PM (TTM) N/A
GM 22.79%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
OMI Yearly Profit, Operating, Gross MarginsOMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), OMI is creating value.
The number of shares outstanding for OMI has been increased compared to 1 year ago.
The number of shares outstanding for OMI has been increased compared to 5 years ago.
The debt/assets ratio for OMI has been reduced compared to a year ago.
OMI Yearly Shares OutstandingOMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OMI Yearly Total Debt VS Total AssetsOMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 1.93 indicates that OMI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.93, OMI perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.93
ROIC/WACC1.98
WACC6.69%
OMI Yearly LT Debt VS Equity VS FCFOMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.86 indicates that OMI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.86, OMI is doing worse than 80.00% of the companies in the same industry.
OMI has a Quick Ratio of 0.86. This is a bad value and indicates that OMI is not financially healthy enough and could expect problems in meeting its short term obligations.
OMI's Quick ratio of 0.83 is on the low side compared to the rest of the industry. OMI is outperformed by 74.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.83
OMI Yearly Current Assets VS Current LiabilitesOMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

3. Growth

3.1 Past

The earnings per share for OMI have decreased strongly by -22.29% in the last year.
The Earnings Per Share has been growing by 22.10% on average over the past years. This is a very strong growth
Looking at the last year, OMI shows a small growth in Revenue. The Revenue has grown by 3.55% in the last year.
OMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.04% yearly.
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%

3.2 Future

Based on estimates for the next years, OMI will show a decrease in Earnings Per Share. The EPS will decrease by -1.16% on average per year.
Based on estimates for the next years, OMI will show a very negative growth in Revenue. The Revenue will decrease by -26.97% on average per year.
EPS Next Y-31.11%
EPS Next 2Y-20.17%
EPS Next 3Y-9.79%
EPS Next 5Y-1.16%
Revenue Next Year-73.87%
Revenue Next 2Y-49.96%
Revenue Next 3Y-35.61%
Revenue Next 5Y-26.97%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OMI Yearly Revenue VS EstimatesOMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
OMI Yearly EPS VS EstimatesOMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.29, which indicates a rather cheap valuation of OMI.
OMI's Price/Earnings ratio is rather cheap when compared to the industry. OMI is cheaper than 100.00% of the companies in the same industry.
OMI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.28.
OMI is valuated cheaply with a Price/Forward Earnings ratio of 3.05.
Based on the Price/Forward Earnings ratio, OMI is valued cheaply inside the industry as 99.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 33.61, OMI is valued rather cheaply.
Industry RankSector Rank
PE 2.29
Fwd PE 3.05
OMI Price Earnings VS Forward Price EarningsOMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OMI is valued cheaper than 94.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.37
OMI Per share dataOMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

A cheap valuation may be justified as OMI's earnings are expected to decrease with -9.79% in the coming years.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-20.17%
EPS Next 3Y-9.79%

0

5. Dividend

5.1 Amount

No dividends for OMI!.
Industry RankSector Rank
Dividend Yield N/A

OWENS & MINOR INC

NYSE:OMI (11/10/2025, 8:19:58 PM)

After market: 2.9507 +0 (+0.02%)

2.95

-0.23 (-7.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-26 2026-02-26/amc
Inst Owners100.37%
Inst Owner Change-4.88%
Ins Owners3.61%
Ins Owner Change1.95%
Market Cap227.86M
Revenue(TTM)10.70B
Net Income(TTM)-1.20B
Analysts51.67
Price Target6.3 (113.56%)
Short Float %11.32%
Short Ratio3.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.19%
Min EPS beat(2)-6.28%
Max EPS beat(2)16.66%
EPS beat(4)3
Avg EPS beat(4)3.96%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)7
Avg EPS beat(8)6.12%
EPS beat(12)10
Avg EPS beat(12)14.68%
EPS beat(16)13
Avg EPS beat(16)14.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.75%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-1.97%
Revenue beat(4)1
Avg Revenue beat(4)-1.39%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)0.52%
Revenue beat(8)1
Avg Revenue beat(8)-1.05%
Revenue beat(12)5
Avg Revenue beat(12)0.26%
Revenue beat(16)8
Avg Revenue beat(16)0.29%
PT rev (1m)0.57%
PT rev (3m)-38.25%
EPS NQ rev (1m)-1.56%
EPS NQ rev (3m)-48.94%
EPS NY rev (1m)1.45%
EPS NY rev (3m)-37.45%
Revenue NQ rev (1m)6.9%
Revenue NQ rev (3m)-59.53%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)-74.57%
Valuation
Industry RankSector Rank
PE 2.29
Fwd PE 3.05
P/S 0.03
P/FCF N/A
P/OCF 2.26
P/B N/A
P/tB N/A
EV/EBITDA 4.37
EPS(TTM)1.29
EY43.73%
EPS(NY)0.97
Fwd EY32.84%
FCF(TTM)-2.15
FCFYN/A
OCF(TTM)1.31
OCFY44.26%
SpS113.04
BVpS-3.64
TBVpS-22.06
PEG (NY)N/A
PEG (5Y)0.1
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -28.95%
ROE N/A
ROCE 16.79%
ROIC 13.26%
ROICexc 13.61%
ROICexgc 1049.61%
OM 2.85%
PM (TTM) N/A
GM 22.79%
FCFM N/A
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexgc growth 3Y-4.88%
ROICexgc growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score4
Asset Turnover2.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 3.22
Cap/Depr 108.01%
Cap/Sales 3.06%
Interest Coverage 1.82
Cash Conversion 20.34%
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.83
Altman-Z 1.93
F-Score4
WACC6.69%
ROIC/WACC1.98
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
EPS Next Y-31.11%
EPS Next 2Y-20.17%
EPS Next 3Y-9.79%
EPS Next 5Y-1.16%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%
Revenue Next Year-73.87%
Revenue Next 2Y-49.96%
Revenue Next 3Y-35.61%
Revenue Next 5Y-26.97%
EBIT growth 1Y-19.73%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year24.04%
EBIT Next 3Y7.75%
EBIT Next 5YN/A
FCF growth 1Y-139.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.91%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%

OWENS & MINOR INC / OMI FAQ

Can you provide the ChartMill fundamental rating for OWENS & MINOR INC?

ChartMill assigns a fundamental rating of 3 / 10 to OMI.


What is the valuation status for OMI stock?

ChartMill assigns a valuation rating of 6 / 10 to OWENS & MINOR INC (OMI). This can be considered as Fairly Valued.


What is the profitability of OMI stock?

OWENS & MINOR INC (OMI) has a profitability rating of 4 / 10.


What is the valuation of OWENS & MINOR INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for OWENS & MINOR INC (OMI) is 2.29 and the Price/Book (PB) ratio is -0.81.


What is the financial health of OWENS & MINOR INC (OMI) stock?

The financial health rating of OWENS & MINOR INC (OMI) is 2 / 10.